美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Generate Biomedicines

12.61

+0.11000.88%

盤後：12.610.00000.00%17:23 EDT

成交量：29.14萬

成交額：367.22萬

市值：16.07億

市盈率：-6.44

高：12.88

開：12.60

低：12.35

收：12.50

52周最高：15.32

52周最低：11.00

股本：1.27億

流通股本：2,500.00萬

量比：0.85

換手率：1.17%

股息：- -

股息率：- -

每股收益(TTM):-1.9580

每股收益(LYR):-4.9816

淨資產收益率：-81.72%

總資產收益率：-34.63%

市淨率：-2.61

市盈率(LYR):-2.53

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Generate Biomedicines

交易所：

NASDAQ

成立時間：

2018

員工人數：

312

公司地址：

101 South Street,Suite 900,Somerville,Massachusetts,United States

官網：

http://www.generatebiomedicines.com

郵編：

02143

電話：

傳真：

- -

簡介：

Generate Biomedicines, Inc.於2018年8月根據特拉華州法律成立。作為一家臨床階段的生成生物學公司，該公司首創了名為Generate Platform的人工智能驅動的生物技術平台，該平台將計算模型與可擴展的生物硬件相結合，以設計和開發新型治療性蛋白質。其最先進的候選藥物GB-0895是一種計算工程抗TSLP單克隆抗體，目前正處於嚴重哮喘的關鍵3期試驗中。該平台的能力已通過在2026年將另外兩個腫瘤候選藥物推向1期試驗而得到進一步證明。

董事

名稱

職位

Michael Nally

Chief Executive Officer and Director

Noubar B. Afeyan

Chairperson of the Board

Frances Arnold

Director

Jane Mendillo

Director

Marsha H. Fanucci

Director

Nancy A. Simonian

Director

Paul Parker

Director

Rupert Vessey

Director

Stéphane Bancel

Director

股東

名稱

職位

Michael Nally

Chief Executive Officer and Director

Jason Silvers

Chief Financial Officer and President

Aarif Khakoo

Chief Scientific Officer

Beth Grous

Chief People Officer

Gevorg Grigoryan

Chief Technology Officer and Co-Founder

Laurie Lee

Chief Medical Officer

Sean Martin

Chief Legal Officer and General Counsel

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GENB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GENB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","market":"US","secType":"STK","nameCN":"Generate Biomedicines","latestPrice":12.61,"timestamp":1776369600000,"preClose":12.5,"halted":0,"volume":291397,"hourTrading":{"tag":"盘后","latestPrice":12.61,"preClose":12.61,"latestTime":"17:23 EDT","volume":610,"amount":7691.9,"timestamp":1776374616462,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.008799999999999954,"floatShares":25000000,"shares":127450200,"eps":-1.958,"marketStatus":"未開盤","change":0.11,"latestTime":"04-16 16:00:00 EDT","open":12.6,"high":12.88,"low":12.35,"amount":3672204.808996,"amplitude":0.0424,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.958,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"listingDate":1772168400000,"exchange":"NASDAQ","adjPreClose":12.5,"preHourTrading":{"tag":"盘前","latestPrice":12.51,"preClose":12.5,"latestTime":"09:28 EDT","volume":190,"amount":2424.00993,"timestamp":1776346119624,"change":0.01,"changeRate":0.0008,"amplitude":0.036},"postHourTrading":{"tag":"盘后","latestPrice":12.61,"preClose":12.61,"latestTime":"17:23 EDT","volume":610,"amount":7691.9,"timestamp":1776374616462,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.853717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","floatShares":25000000,"roa":"-34.63%","roe":"-81.72%","lyrEps":-4.981642,"volumeRatio":0.853717,"shares":127450200,"dividePrice":0,"high":12.88,"amplitude":0.0424,"preClose":12.5,"low":12.35,"week52Low":11,"pbRate":"-2.61","psRate":"50.39","week52High":15.32,"institutionHeld":0,"latestPrice":12.61,"eps":-1.958,"divideRate":0,"volume":291397,"delay":0,"ttmEps":-1.958,"open":12.6,"prevYearClose":16,"prevWeekClose":11.41,"prevMonthClose":12.5,"prevQuarterClose":12.5,"fiveDayClose":11.53,"twentyDayClose":11.81,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GENB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GENB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GENB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1776139200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GENB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GENB","date":"2026-04-15","current":-6.440245,"percent":0.15625,"low":-10.037721,"twenty":-8.048998,"median":-7.660036,"eighty":-7.414112,"high":-7.032678,"avg":-7.763645,"sd":0.548051,"marketCap":1642833090},"quantilePoints":[{"date":"2026-02-27","current":-10.037721,"twenty":-10.037721,"median":-10.037721,"eighty":-10.037721,"marketCap":2039203216},{"date":"2026-03-06","current":-7.810602,"twenty":-7.936073,"median":-7.722772,"eighty":-7.484376,"marketCap":1586755002},{"date":"2026-03-13","current":-8.331309,"twenty":-7.979988,"median":-7.660036,"eighty":-7.484376,"marketCap":1692538669},{"date":"2026-03-20","current":-7.710225,"twenty":-7.979988,"median":-7.68513,"eighty":-7.484376,"marketCap":1566362970},{"date":"2026-03-27","current":-8.061545,"twenty":-7.979988,"median":-7.697677,"eighty":-7.484376,"marketCap":1637735082},{"date":"2026-04-02","current":-8.350129,"twenty":-7.996299,"median":-7.697677,"eighty":-7.419131,"marketCap":1696362175},{"date":"2026-04-10","current":-7.233433,"twenty":-7.996299,"median":-7.647489,"eighty":-7.419131,"marketCap":1469500817},{"date":"2026-04-15","current":-8.086639,"twenty":-8.048998,"median":-7.660036,"eighty":-7.414112,"marketCap":1642833090}],"updateTime":1776397228341},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":659065371,"yearFounded":2018,"employeeNum":312,"address":"101 South Street,Suite 900,Somerville,Massachusetts,United States","zipCode":"02143","officePhone":"(888) 469-0055","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.generatebiomedicines.com","stockEarnings":[{"period":"1week","weight":0.0937},{"period":"1month","weight":0.0202},{"period":"3month","weight":-0.2119},{"period":"ytd","weight":-0.2119}],"compareEarnings":[{"period":"1week","weight":0.032},{"period":"1month","weight":0.046},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.0561},{"period":"1year","weight":0.3348},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Generate Biomedicines, Inc.於2018年8月根據特拉華州法律成立。作為一家臨床階段的生成生物學公司，該公司首創了名為Generate Platform的人工智能驅動的生物技術平台，該平台將計算模型與可擴展的生物硬件相結合，以設計和開發新型治療性蛋白質。其最先進的候選藥物GB-0895是一種計算工程抗TSLP單克隆抗體，目前正處於嚴重哮喘的關鍵3期試驗中。該平台的能力已通過在2026年將另外兩個腫瘤候選藥物推向1期試驗而得到進一步證明。","exchange":"NASDAQ","name":"Generate Biomedicines","nameEN":"Generate Biomedicines"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GENB\",market:\"US\",,,undefined,":{"directors":[{"name":"Michael Nally","position":"Chief Executive Officer and Director"},{"name":"Noubar B. Afeyan","position":"Chairperson of the Board"},{"name":"Frances Arnold","position":"Director"},{"name":"Jane Mendillo","position":"Director"},{"name":"Marsha H. Fanucci","position":"Director"},{"name":"Nancy A. Simonian","position":"Director"},{"name":"Paul Parker","position":"Director"},{"name":"Rupert Vessey","position":"Director"},{"name":"Stéphane Bancel","position":"Director"}],"executives":[{"name":"Michael Nally","position":"Chief Executive Officer and Director"},{"name":"Jason Silvers","position":"Chief Financial Officer and President"},{"name":"Aarif Khakoo","position":"Chief Scientific Officer"},{"name":"Beth Grous","position":"Chief People Officer"},{"name":"Gevorg Grigoryan","position":"Chief Technology Officer and Co-Founder"},{"name":"Laurie Lee","position":"Chief Medical Officer"},{"name":"Sean Martin","position":"Chief Legal Officer and General Counsel"}]}}}